Role of the Prognostic Nutritional Index in Patients With Soft-tissue Sarcoma
- PMID: 34182517
- PMCID: PMC8286482
- DOI: 10.21873/invivo.12511
Role of the Prognostic Nutritional Index in Patients With Soft-tissue Sarcoma
Abstract
Background: This study aimed to determine whether the prognostic nutritional index (PNI) can predict the prognosis in patients with soft-tissue sarcoma (STS) before treatment and to examine whether there is an association between PNI values and clinical characteristics.
Patients and methods: The data on 100 patients with primary STS were retrospectively reviewed. The cohort included 55 men and 45 women, with a mean age of 64 years. The mean follow-up duration was 41.7 months.
Results: The median PNI was 51.35. The PNI was significantly inversely associated with tumor size, tumor grade, and age. We found that the PNI was a significant prognostic marker for disease-specific and event-free survival using univariate and multivariate analyses. Patients with a low PNI had poorer disease-specific and event-free survival than those with a high PNI.
Conclusion: These results suggest that the PNI can be used as a prognostic marker in patients with STS.
Keywords: Prognostic nutritional index; soft tissue sarcoma; survival..
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Conflict of interest statement
There were no conflicts of interest in this study.
Figures




References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical